Human tumour antigens recognized by T cells: New perspectives for anti- cancer vaccines?

Molecular Medicine Today

Volumn 3, Issue 6, 1997, Pages 261-268

  Coulie, P G ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; DNA VACCINE; LIVE VACCINE; MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE; MUCIN LIKE CARCINOMA ASSOCIATED ANTIGEN; TUMOR ANTIGEN; VIRUS ANTIGEN;

ADOPTIVE TRANSFER; ANTIGEN RECOGNITION; ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; CANCER; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; HUMAN; KIDNEY CARCINOMA; MELANOMA; NONHUMAN; REVIEW; WART VIRUS;

EID: 0031414141     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)01049-6     Document Type: Review

References (39)

1. Boon T. Tumor antigens recognized by T lymphocytes Annu. Rev. Immunol. 12 1994 337 365
2. De Plaen, E. et al. Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes , Methods Journal (in press)
3. van der Bruggen P. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 254 1991 1643 1647
4. Rogner U.C. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28 Genomics 29 1995 725 731
5. De Plaen E. Structure, chromosomal localization and expression of twelve genes of the MAGE family Immunogenetics 40 1994 360 369
6. Chomez P. The SMAGE gene family is expressed in post-meiotic spermatids during mouse germ cell differentiation Immunogenetics 43 1995 97 100
7. Takahashi K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis Cancer Res. 55 1995 3478 3482
8. Brasseur F. Expression of MAGE genes in primary and metastatic cutaneous melanoma Int. J. Cancer 63 1995 375 380
9. Weynants P. Expression of MAGE genes by non-small-cell lung carcinomas Int. J. Cancer 56 1994 826 829
10. Patard J-J Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder Int. J. Cancer 64 1995 60 64
11. Traversari C. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E J. Exp. Med. 176 1992 1453 1457
12. van der Bruggen P. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601 Eur. J. Immunol. 24 1994 2134 2140
13. Gaugler B. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes J. Exp. Med. 179 1994 921 930
14. van der Bruggen P. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3 Eur. J. Immunol. 24 1994 3038 3043
15. Herman J. A peptide encoded by human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3 Immunogenetics 43 1996 377 383
16. Celis E. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes Proc. Natl. Acad. Sci. U. S. A. 91 1994 2105 2109
17. Boël P. BAGE , a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes Immunity 2 1995 167 175
18. Van den Eynde B. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma J. Exp. Med. 182 1995 689 698
19. Gaugler B. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma Immunogenetics 44 1996 323 330
20. Brichard V. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J. Exp. Med. 178 1993 489 495
21. Wölfel T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes Eur. J. Immunol. 24 1994 759 764
22. Coulie P.G. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas J. Exp. Med. 180 1994 35 42
23. Kawakami Y. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes J. Exp. Med. 180 1994 347 352
24. Bakker A.B.H. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes J. Exp. Med. 179 1994 1005 1009
25. Kawakami Y. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression J. Immunol. 154 1995 3961 3968
26. Wang R-F Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen J. Exp. Med. 183 1996 1131 1140
27. Bystryn J-C. Darrell R. Friedman R.J. Kopf A. Prognostic significance of hypopigmentation in malignant melanoma Arch. Dermatol. 123 1987 1053 1055
28. Richards J.M. Mehta N. Ramming K. Skosey P. Sequential chemoimmunotherapy in the treatment of metastatic melanoma J. Clin. Oncol. 10 1992 1338 1343
29. − mutation Proc. Natl. Acad. Sci. U. S. A. 85 1988 2274 2278
30. − transplantation antigen P91A. A peptide encoded by the mutated exon is recognized with Ld by cytolytic T cells Cell 58 1989 293 303
31. INK4a -insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma Science 269 1995 1281 1284
32. Coulie P.G. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma Proc. Natl. Acad. Sci. U. S. A. 92 1995 7976 7980
33. Robbins P.F. A mutated β-catenin gene encodes a melanomaspecific antigen recognized by tumor infiltrating lymphocytes J. Exp. Med. 183 1996 1185 1192
34. Jerome K.R. Domenech N. Finn O.J. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin cDNA J. Immunol. 151 1993 1654 1662
35. Ioannides C.G. Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptide J. Immunol. 151 1993 3693 3703
36. Takahashi T. Expression of MUC-1 on myeloma cells and induction of HLA-unrestricted CTL against MUC-1 from a multiple myeloma patient J. Immunol. 153 1994 2102 2109
37. Rickinson A.B. T cell recognition of Epstein-Barr virus associated lymphomas Cancer Surveys 13 1992 53 80
38. Ressing M.E. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides J. Immunol. 154 1995 5934 5943
39. Marchand M. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3 Int. J. Cancer 63 1995 883 885